1. Home
  2. RPRX vs RTO Comparison

RPRX vs RTO Comparison

Compare RPRX & RTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPRX
  • RTO
  • Stock Information
  • Founded
  • RPRX 1996
  • RTO 1925
  • Country
  • RPRX United States
  • RTO United Kingdom
  • Employees
  • RPRX N/A
  • RTO N/A
  • Industry
  • RPRX Biotechnology: Pharmaceutical Preparations
  • RTO Business Services
  • Sector
  • RPRX Health Care
  • RTO Consumer Discretionary
  • Exchange
  • RPRX Nasdaq
  • RTO Nasdaq
  • Market Cap
  • RPRX 13.9B
  • RTO 12.2B
  • IPO Year
  • RPRX 2020
  • RTO N/A
  • Fundamental
  • Price
  • RPRX $37.85
  • RTO $25.24
  • Analyst Decision
  • RPRX Strong Buy
  • RTO Hold
  • Analyst Count
  • RPRX 4
  • RTO 1
  • Target Price
  • RPRX $46.75
  • RTO N/A
  • AVG Volume (30 Days)
  • RPRX 2.5M
  • RTO 853.6K
  • Earning Date
  • RPRX 08-06-2025
  • RTO 08-12-2025
  • Dividend Yield
  • RPRX 2.38%
  • RTO 2.10%
  • EPS Growth
  • RPRX 43.84
  • RTO N/A
  • EPS
  • RPRX 2.16
  • RTO 0.13
  • Revenue
  • RPRX $2,304,578,000.00
  • RTO $7,581,860,530.00
  • Revenue This Year
  • RPRX $28.60
  • RTO $16.96
  • Revenue Next Year
  • RPRX $8.07
  • RTO $3.19
  • P/E Ratio
  • RPRX $17.14
  • RTO $37.09
  • Revenue Growth
  • RPRX 2.99
  • RTO N/A
  • 52 Week Low
  • RPRX $24.05
  • RTO $19.60
  • 52 Week High
  • RPRX $38.00
  • RTO $34.07
  • Technical
  • Relative Strength Index (RSI)
  • RPRX 57.95
  • RTO 59.68
  • Support Level
  • RPRX $36.27
  • RTO $23.25
  • Resistance Level
  • RPRX $38.00
  • RTO $25.51
  • Average True Range (ATR)
  • RPRX 0.68
  • RTO 0.45
  • MACD
  • RPRX -0.02
  • RTO 0.10
  • Stochastic Oscillator
  • RPRX 64.97
  • RTO 92.93

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

About RTO Rentokil Initial plc

Rentokil Initial is the largest global provider of route-based pest-control and commercial hygiene services, operating in 83 countries. The group also offers a range of specialist route-based services including office and commercial space plant care, property care, and workwear rentals. The group has a diverse client base that includes global food producers, hotel chains, industrial goods businesses, restaurants, and individual residential customers.

Share on Social Networks: